Careers Contact
English
简体
繁体
English 简体 繁体
  • About Us
    Company Profile
    Mission
    Leadership
    Senior Management Board of Directors Scientific Advisory Boards
    Milestones
    Sustainability
  • Innovation
    Discovery
    Translational Research
    Process Development
    Clinical Development
    Manufacturing
  • Products
    Pipeline
    Core products
    Osemitamab TST002 TST003
    Scientific Publications
  • Partnering
  • Investors
  • News & Events
    Press Release
    In The News
    Events
  • About Us
    Company Profile
    Mission
    Leadership
    Senior Management Board of Directors Scientific Advisory Boards
    Milestones
    Sustainability
  • Innovation
    Discovery
    Translational Research
    Process Development
    Clinical Development
    Manufacturing
  • Products
    Pipeline
    Core products
    Osemitamab TST002 TST003
    Scientific Publications
  • Partnering
  • Investors
    Corporate Governance
    Announcements
    Stock Information
    Financial Reports
    Listing Documents
    IR Calendar
    Webcasts & Presentations
    Email Alert
    IR Contact
  • News & Events
    Press Release
    In The News
    Events
  • Contact
  • English
  • 简体
  • 繁体

Investors Relations

Investors Corporate Governance Announcements Stock Information Financial Reports Listing Documents IR Calendar Webcasts & Presentations Email Alert IR Contact

Listing Documents

  • GREEN APPLICATION FORM
    Download
    GREEN APPLICATION FORM
  • GLOBAL OFFERING
    Download
    GLOBAL OFFERING
  • GLOBAL OFFERING
    Download
    GLOBAL OFFERING
Investors
  • Corporate Governance

  • Announcements

  • Stock Information

  • Financial Reports

  • Listing Documents

  • IR Calendar

  • Webcasts & Presentations

  • Email Alert

  • IR Contact

© 2019 TRANSCENTA HOLDING ALL RIGHTS RESERVED.
浙ICP备16042385号-1
Copyright Declaration | Privacy Statement
  • About Us
  • Innovation
  • Products
  • Partnering
  • Investors
  • News & Events
  • Careers
  • Contact Us
Public Relations: pr@transcenta.com
Investor Relations: ir@transcenta.com
Business Development: bd@transcenta.com
Compliance: compliance@transcenta.com